Topical Drug Delivery Market By Product Type (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products), By Route Of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, and Nasal Drug Delivery), By Distribution Of Channel (Retail, and Direct Tenders End User (Clinics, Hospitals, Home Healthcare, Diagnostic Centers, and Others)) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

The Topical Drug Delivery Market Size was valued at USD 317.8 billion in 2023 and is poised to grow at a significant CAGR of 9.3% over 2024-2030. Topical Drug Delivery medication delivery is known to be one of the most effective methods of drug delivery owing to its finest therapeutic benefits. The rising incidences of skin disease and related issues globally are the factors that contribute to the topical drug delivery market growth. Furthermore, increasing benefits of transdermal medicine such as low rejection rate, excellent ease of administration, and outstanding patient convenience and persistence, over oral and ingesting medications (medications for gastrointestinal toxicity) that result in nausea and vomiting, are pushing the demand for the topical drug delivery market. Additionally, due to its non-invasive nature, patches decreased the inconvenience brought on by parenteral or intravenous therapies is propelling the market growth. During covid 19, the topical drug delivery market is hit badly by lockdowns worldwide. That pandemic also hurt the supply and demand chain of raw materials needed to make medications (such as drugs and manufacturing equipment). On the brighter side, the global economy is projected to gradually normalize, with an increase in the manufacturing and transportation of raw materials and associated equipment, resulting in market growth.

Topical Drug Delivery Market Key Developments:
  • In Nov 2021, Nexgel launched MEDAGEL Migraine Relief Patch. The patches draw heat away from the body using Nexgel's proprietary hydrogel technology and provide immediate and long-lasting cooling relief from migraines, fevers, and hormonal headaches.
  • In June 2021, Luye Pharma Group launched the Rivastigmine Transdermal Patch in China for the treatment of mild to moderate Alzheimer's disease.

Topical Drug Delivery Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.3%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Topical Drug Delivery Market Dynamics

People are more likely to develop skin infections such as eczema, psoriasis, and minor ailments including acne these are the key drivers for the topical drug delivery market. Furthermore, the growing incidences of burn injuries, the prevalence of diabetes and eye diseases, and the wide use of drugs to treat diabetic neuropathic pain and foot ulcers are also projected to have a progressive growth rate in the global market. Technical barriers associated with skin irritation and permeability are expected to challenge the topical drug delivery market in the forecast period. The topical drug delivery market is hindered by the presence of various alternative drug delivery modes for patients.

Key Features of the Reports

  • The topical drug delivery market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights into the competitor's overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and startup details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter Five Force Analysis in addition to recent technology advancements and innovations in the market

Topical Drug Delivery Market Segmentation

By Product Type
  • Semi-Solid Formulations
  • Liquid Formulations
  • Solid Formulations
  • Transdermal Products
By Distribution Channel
  • Retail
  • Direct Tenders
By End User
  • Clinics
  • Hospitals
  • Home Healthcare
  • Diagnostic Centers
  • Others

Frequently Asked Questions

Applying medication to the skin or mucous membranes allows it to enter the body from there. Medication applied in this way is known as a topical medication. It can also be used to treat pain or other diseases in specific parts of the body.

Transdermal products are administered to the skin and the drugs permeate into the systemic circulation and are sent throughout the body to the targeted section

Rising skin infections such as eczema, psoriasis, and minor ailments including acne and research and development in the healthcare infrastructure.

1. Executive Summary
2. Global Topical Drug Delivery Market Introduction
2.1. Global Topical Drug Delivery Market - Taxonomy
2.2. Global Topical Drug Delivery Market -Definitions
2.2.1. Product Type
2.2.2. Route Of Administration
2.2.3. Distribution channel
2.2.4. End User
2.2.5. Geography
3. Global Topical Drug Delivery Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Topical Drug Delivery Market Dynamic Factors - Impact Analysis
3.6. Global Topical Drug Delivery Market - Competition Landscape
4. Global Topical Drug Delivery Market Analysis,2019 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Topical Drug Delivery Market, By Product Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Semi-Solids Formulations
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Liquid Formulations
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Solids Formulations
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Transdermal Products
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global Topical Drug Delivery Market, By Route Of Administration, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1. Dermal Drug Delivery
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Ophthalmic Drug Delivery
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Rectal Drug Delivery
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Vaginal Drug Delivery
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Nasal Drug Delivery
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Topical Drug Delivery Market Forecast, By Distribution Channel, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Retail
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Direct Tenders
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Topical Drug Delivery Market Forecast, By End User, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1. Clinics
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Hospitals
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Home Healthcare
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Diagnostics Centre’s
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Others
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
9. Global Topical Drug Delivery Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Topical Drug Delivery Market - Opportunity Analysis Index, By Product Type, Route Of Administration, Distribution Channel, End User, and Region, 2024 - 2030
10. North America Topical Drug Delivery market analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Product Type Analysis 2017-2021and Forecast 2024 - 2030by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Semi-Solid Formulations
10.1.2. Liquid Formulations
10.1.3. Solid Formulations
10.1.4. Transdermal Products
10.2. Route Of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Dermal Drug Delivery
10.2.2. Ophthalmic Drug Delivery
10.2.3. Rectal Drug Delivery
10.2.4. Vaginal Drug Delivery
10.2.5. Nasal Drug Delivery
10.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Retail
10.3.2. Direct Tenders
10.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Clinics
10.4.2. Hospitals
10.4.3. Home Healthcare
10.4.4. Diagnostic Centers
10.4.5. Others
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Topical Drug Delivery Market - Opportunity Analysis Index, By Product Type, Route Of Administration, Distribution Channel, End User, and Region, 2024 - 2030
10.7. North America Topical Drug Delivery Market Dynamics - Trends
11. Europe Topical Drug Delivery Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Product Type Analysis 2017-2021and Forecast 2024 - 2030by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Semi-Solid Formulations
11.1.2. Liquid Formulations
11.1.3. Solid Formulations
11.1.4. Transdermal Products
11.2. Route Of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Dermal Drug Delivery
11.2.2. Ophthalmic Drug Delivery
11.2.3. Rectal Drug Delivery
11.2.4. Vaginal Drug Delivery
11.2.5. Nasal Drug Delivery
11.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Retail
11.3.2. Direct Tenders
11.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Clinics
11.4.2. Hospitals
11.4.3. Home Healthcare
11.4.4. Diagnostic Centers
11.4.5. Others
11.5. Country Analysis 2017-2021and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Topical Drug Delivery Market - Opportunity Analysis Index, By Product Type, Route Of Administration, Distribution Channel, End User, and Region, 2024 - 2030
11.7. Europe Topical Drug Delivery Market Dynamics - Trends
12. Asia-Pacific Topical Drug Delivery Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
12.1. Product Type Analysis 2017-2021and Forecast 2024 - 2030by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Semi-Solid Formulations
12.1.2. Liquid Formulations
12.1.3. Solid Formulations
12.1.4. Transdermal Products
12.2. Route Of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Dermal Drug Delivery
12.2.2. Ophthalmic Drug Delivery
12.2.3. Rectal Drug Delivery
12.2.4. Vaginal Drug Delivery
12.2.5. Nasal Drug Delivery
12.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Retail
12.3.2. Direct Tenders
12.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Clinics
12.4.2. Hospitals
12.4.3. Home Healthcare
12.4.4. Diagnostic Centers
12.4.5. Others
12.5. Country Analysis2017-2021and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Topical Drug Delivery Market - Opportunity Analysis Index, By Product Type, Route Of Administration, Distribution Channel, End User, and Region, 2024 - 2030
12.7. Asia-Pacific Topical Drug Delivery Market Dynamics - Trends
13. Latin America Topical Drug Delivery Market Analysis,2019 - 2023 and Forecast, 2022-2028(Revenue, USD Mn)
13.1. Product Type Analysis 2017-2021and Forecast 2024 - 2030by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Semi-Solid Formulations
13.1.2. Liquid Formulations
13.1.3. Solid Formulations
13.1.4. Transdermal Products
13.2. Route Of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Dermal Drug Delivery
13.2.2. Ophthalmic Drug Delivery
13.2.3. Rectal Drug Delivery
13.2.4. Vaginal Drug Delivery
13.2.5. Nasal Drug Delivery
13.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Retail
13.3.2. Direct Tenders
13.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Clinics
13.4.2. Hospitals
13.4.3. Home Healthcare
13.4.4. Diagnostic Centers
13.4.5. Others
13.5. Country Analysis 2017-2021and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Rest of Latin America
13.6. Latin America Topical Drug Delivery Market - Opportunity Analysis Index, By Product Type, Route Of Administration, Distribution Channel, End User, and Region, 2024 - 2030
13.7. Latin America Topical Drug Delivery Market Dynamics - Trends
14. Middle East and Africa Topical Drug Delivery Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
14.1. Product Type Analysis 2017-2021and Forecast 2024 - 2030by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Semi-Solid Formulations
14.1.2. Liquid Formulations
14.1.3. Solid Formulations
14.1.4. Transdermal Products
14.2. Route Of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Dermal Drug Delivery
14.2.2. Ophthalmic Drug Delivery
14.2.3. Rectal Drug Delivery
14.2.4. Vaginal Drug Delivery
14.2.5. Nasal Drug Delivery
14.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Retail
14.3.2. Direct Tenders
14.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Clinics
14.4.2. Hospitals
14.4.3. Home Healthcare
14.4.4. Diagnostic Centers
14.4.5. Others
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Topical Drug Delivery Market - Opportunity Analysis Index, By Product Type, Route Of Administration, Distribution Channel, End User, and Region, 2024 - 2030
14.7. MEA Topical Drug Delivery Market Dynamics - Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product Type& Service Testing Types, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Johnson & Johnson Private Limited (U.S.)
15.2.2. Allergan (Ireland)
15.2.3. Nestlé India Ltd., (Switzerland)
15.2.4. Merck & Co Inc., (U.S.)
15.2.5. Novartis AG (Switzerland)
15.2.6. GlaxoSmithKline plc (U.K)
15.2.7. Bausch Health Companies Inc., (Canada)
15.2.8. Bayer AG (Germany),
15.2.9. Crescita Therapeutics (Canada)
15.2.10. LEO Pharma A/S (Denmark)
15.2.11. Hisamitsu Pharmaceutical Co., Inc. (Japan)
15.2.12. Glenmark Pharmaceuticals Limited, (India)
15.2.13. Cipla Inc., (India)
15.2.14. Mylan N.V. (U.S.)
15.2.15. Encore Dermatology, (U.S.)
16. Research Methodology
17. Key Assumptions and Acronyms
  • Johnson & Johnson Private Limited 
  • Allergan 
  • Nestle India Ltd.
  • Merck & Co Inc.
  • Novartis AG 
  • GlaxoSmithKline plc 
  • Bausch Health Companies Inc.
  • Bayer AG 
  • Crescita Therapeutics 
  • LEO Pharma A/S 
  • Hisamitsu Pharmaceutical Co., Inc.
  • Glenmark Pharmaceuticals Limited
  • Cipla Inc., 
  • Mylan N.V.
  • Encore Dermatology

Adjacent Markets